Antibody Production

Monoclonal antibodies are the basis of modern, targeted therapies. The production of long-lasting antibody-producing hybridoma cells, followed by antibody manufacturing and purification, requires coordinated process steps. These antibody-producing cells are often generated using the hybridoma technique, in which B cells are fused with myeloma cells. The resulting hybridoma cells combine the antibody-producing capability of B cells with the longevity and robustness of myeloma cells. Our product range covers both upstream and downstream processes: UPSTREAM PROCESSING (USP) - Media, supplements and reagents for hybridoma generation and expansion - Custom formulations to support screening and optimization DOWNSTREAM PROCESSING (DSP) - Specialized media and reagents for antibody production - Purification solutions for highly pure monoclonal antibodies PAN-Biotech offers high-quality standard products and customized sterile formulations for efficient and reliable antibody production. Our products are also available in small quantities. Our sterile solutions are filled in cGMP quality from 10 L and produced in GMP quality from 25 L.